SD Hosted Joint Quarter: CDA Product Family -This meeting is to provide an update to all interested work groups regarding the formation of a CDA Product Family. There will be many work groups invited to participate, so send representatives only

Joint meeting with CS, OO, and PC. Per Hans, typically this one is very short (as it is in maintenance mode). Rest of the quarter is strictly OO. OO doesn't want to lose it from the radar, but no problem if PC declines, or puts down one representative who can check whether anything worthwhile comes up

San Diego, WGM - Sept 2017. Patient Care WG Meeting Meeting Minutes

Sunday, Sept 10

International Council Meeting

PCWG Care Plan

Q5

Discussion re: CP DAM 2.0

- Attendance:

- Emma Jones

- Laura Heernman

- Stephen Chu

- Notes:

Discuss Care Plan DAM 2.0: What to include/what does 2.0 look like:

• Orders (pull it up more visible). Figure 6 in the DAM. We need to improve the figure to represent activities and orders into other (higher level diagrams Level 0, or 0.5? Unpack the order set concepts. (what has been done in the FHIR Connectathons – how the library of activity definition fits into the activity box itself to form into Order Sets.

• Address Order Sets – how are they derived? How do they fit into the Care Plan? Address protocols… Evidence based guidelines.

• Advance Directives – is there stuff we need to do there? Write to it? How do they fit together?- Are these the same as Patient Orders? A Patient Specified Protocol?

• Health Concern – bring in the latest and greatest from the work that has been done there.

• Reconciliation – being in the latest and greatest from the work that has been done there.

• Care Team – bring in the latest and greatest from the work that is being done there.

• Allergies - bring in the latest and greatest from the work that is being done there.

- Make any changes to the diagram as learned from the FHIR harmonization.

- Write a paragraph – or section regarding FHIR and the harmonization work.

uses spreadsheet to request content. The spreadsheet is the initial input for the tooling.

use of present/absent - use is to qualify clinical statement. this is the highest level of the abstract model, not expected as part of the implementation.

Initial attempt is to have the information to get started

Question is the assertion, answers are in the value set

Podiatry use case

Foot wound has additional attributes

Identifying not only what the wound looks like but the etiology of the wound and additional attributes to understand options for treatment.

Using the same attributes in the model but will have different value set

Interest in looking at the evidentry source information - will CIMI capture the source of where the information came from? DOJ can not copy. Is it in scope that the foot wound source information was not copied from the PE 6 months ago

CIMI has an extensive provenance infrastruture

Implementation is not in the model

Missing extra properties that may be needed. This is the first pass with the goal of getting the process in place. Next stage will be the analysis

Have to start modeing based on the requirements you have. The model will evolve.

Project meets friday morning weekly

Interest from DEEDs on how to consume it. How do we reference it?

This is related to the governance. Need to know who is using what so if changes will need to notify the user.

Adverse event CIMI modeling - PC Thursday Q3

Challenges - more thatn one way to represent information. In a given situation, what is the information I should collect?

Need to differentiate the preferred way to collect the information is being dealt with the CIIC group.